Ocugen in a statement on Thursday announced that as recommended by theFDA,it will pursue submission of a biologics licence application (BLA) for Covaxin.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pIoVJN
via IFTTT
FDA rejects EUA for Covaxin, 'suggests' Biologics Licence Application route for approval in US
Ocugen in a statement on Thursday announced that as recommended by theFDA,it will pursue submission of a biologics licence application (BLA) for Covaxin.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pIoVJN
via IFTTT
0 comments:
Post a Comment